Vous êtes ici : Accueil > Publications IMIV



Publié le 15 mai 2017

Auvity S, Goutal S, Thézé B, Chaves C, Hosten B, Kuhnast B, Saba W, Boisgard R, Buvat I, Cisternino S, Tournier N. Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal. Drug Alcohol Depend. 2017 Jan 1;170:43-50. doi: 10.1016/j.drugalcdep.2016.10.037. Epub 2016 Nov 8. 

Auvity S, Saba W, Goutal S, Leroy C, Buvat I, Cayla J, Caillé F, Bottlaender M, Cisternino S, Tournier N Acute morphine exposure increases the brain distribution of [18F]DPA-714, a PET biomarker of glial activation in nonhuman primates. Int. J. Neuropsychopharmacology. 2017; 20: 67-71.

Bauer M, Karch R, Tournier N, Cisternino S, Wadsak W, Hacker M, Marhofer P, Zeitlinger M, Langer O. Assessment of P-Glycoprotein Transport Activity at the Human Blood-Retina Barrier with (R)-11C-Verapamil PET. J Nucl Med. 2017 Apr;58(4):678-681. 

Bergeret-Cassagne H, Lazard DS, Lefort M, Hachi S, Leenhardt L, Menegaux F, Russ G, Trésallet C, Frouin F. Sonographic Dynamic Description of the Laryngeal Tract: Definition of Quantitative Measures to Characterize Vocal Fold Motion and Estimation of Their Normal Values. J Ultrasound Med. 2017 May;36(5):1037-1044. doi: 10.7863/ultra.16.05014. Epub 2017 Jan 10. 

Cacheux F, Médran-Navarrete V, Dollé F, Marguet F, Puech F, Damont A. Synthesis and in vitro characterization of novel fluorinated derivatives of the translocator protein 18 kDa ligand CfO-DPA-714. Eur J Med Chem. 2017 Jan 5;125:346-359. 

Chassoux F, Artiges E, Semah F, Laurent A, Landré E, Turak B, Gervais P, Helal BO, Devaux B. 18F-FDG-PET patterns of surgical success and failure in mesial temporal lobe epilepsy. Neurology. 2017 Mar 14;88(11):1045-1053. doi: 10.1212/WNL.0000000000003714. Epub 2017 Feb 10. 

Doury M, Dizeux A, de Cesare A, Lucidarme O, Pellot-Barakat C, Bridal SL, Frouin F. Quantification of tumor perfusion using dynamic contrast-enhanced ultrasound: impact of mathematical modeling. Phys Med Biol. 2017 Feb 7;62(3):1113-1125. 

Eberl S, Katsifis A, Peyronneau MA, Wen L, Henderson D, Loc'h C, Greguric I, Verschuer J, Pham T, Lam P, Mattner F, Mohamed A, Fulham MJ. Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111. Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):296-307. 

Feng X, Deistung A, Dwyer MG, Hagemeier J, Polak P, Lebenberg J, Frouin F, Zivadinov R, Reichenbach JR, Schweser F. An improved FSL-FIRST pipeline for subcortical gray matter segmentation to study abnormal brain anatomy using quantitative susceptibility mapping (QSM). Magn Reson Imaging. 2017 Jun;39:110-122. doi: 10.1016/j.mri.2017.02.002. Epub 2017 Feb 7. 

García-Lorenzo D, Lavisse S, Leroy C, Wimberley C, Bodini B, Remy P, Veronese M, Turkheimer F, Stankoff B, Bottlaender M. Validation of an automatic reference region extraction for the quantification of [18F]DPA-714 in dynamic brain PET studies. J Cereb Blood Flow Metab. 2017 Jan 1:271678X17692599. doi: 10.1177/0271678X17692599. 

Gaté L, Disdier C, Cosnier F, Gagnaire F, Devoy J, Saba W, Brun E, Chalansonnet M, Mabondzo A. Biopersistence and translocation to extrapulmonary organs of titanium dioxide nanoparticles after subacute inhalation exposure to aerosol in adult and elderly rats. Toxicol Lett. 2017 Jan 4;265:61-69. 

Lagarde J, Sarazin M, Chauviré V, Stankoff B, Kas A, Lacomblez L, Peyronneau MA, Bottlaender M. Cholinergic Changes in Aging and Alzheimer Disease: An [18F]-F-A-85380 Exploratory PET Study. Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):8-12.

Lebon V, Jan S, Fontyn Y, Tiret B, Pottier G, Jaumain E, Valette J. Using 31P-MRI of hydroxyapatite for bone attenuation correction in PET-MRI: proof of concept in the rodent brain. EJNMMI Phys. 2017 Dec;4(1):16. 

Magalhães R, Bourgin J, Boumezbeur F, Marques P, Bottlaender M, Poupon C, Djemaï B, Duchesnay E, Mériaux S, Sousa N, Jay TM, Cachia A. White matter changes in microstructure associated with a maladaptive response to stress in rats. Transl Psychiatry. 2017 Jan 24;7(1):e1009. doi: 10.1038/tp.2016.283. 

Marie S, Cisternino S, Buvat I, Declèves X, Tournier N. Imaging probes and modalities for the study of Solute Carrier O (SLCO)-transport function in vivo. J Pharm Sci. 2017 Apr 25. pii: S0022-3549(17)30266-6. doi: 10.1016/j.xphs.2017.04.031. [Epub ahead of print]

Nanni C, Cottereau AS, Lopci E, Bodet-Milin C, Coronado M, Pro B, Kim WS, Trotman J, Barrington S, Duhrsen U, Vander Borght T, Zamagni E, Kraeber-Bodéré F, Messiou C, Rahmouni A, Buvat I, Andre M, Hertzberg M, Oyen W, Casasnovas O, Luminari S, Garderet L, Montravers F, Kobe C, Kluge R, Versari A, Zucca E, Moreau P, Cheson B, Haioun C, Gallamini A, Meignan M. Report of the 6th International Workshop on PET in lymphoma. Leuk Lymphoma. 2017 Mar 7:1-6. doi: 10.1080/10428194.2017.1298752. [Epub ahead of print]

Orlhac F, Nioche C, Soussan M, Buvat I. Understanding Changes in Tumor Texture Indices in PET: A Comparison Between Visual Assessment and Index Values in Simulated and Patient Data. J Nucl Med. 2017 Mar;58(3):387-392. doi: 10.2967/jnumed.116.181859. Epub 2016 Oct 6.  

Pottier G, Gómez-Vallejo V, Padro D, Boisgard R, Dollé F, Llop J, Winkeler A, Martín A. PET imaging of cannabinoid type 2 receptors with [11C]A-836339 did not evidence changes following neuroinflammation in rats. J Cereb Blood Flow Metab. 2017 Mar;37(3):1163-1178. doi: 10.1177/0271678X16685105. 

Reuzé S, Orlhac F, Chargari C, Nioche C, Limkin E, Riet F, Escande A, Haie-Meder C, Dercle L, Gouy S, Buvat I, Deutsch E, Robert C.  Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners. Oncotarget. sous presse, 2017. 

Stockhoff M, Jan S, Dubois A, Cherry S, Roncali E. Advanced optical simulation of scintillation detectors in GATE V8.0: first implementation of a reflectance model based on measured data. Phys Med Biol. 2017 Apr 28. doi: 10.1088/1361-6560/aa7007. 

Tournier N, Goutal S, Auvity S, Traxl A, Mairinger S, Wanek T, Helal OB, Buvat I, Soussan M, Caillé F, Langer O. Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood-Brain Barrier: A PET Study on Nonhuman Primates. J Nucl Med. 2017 Jan;58(1):117-122. doi: 10.2967/jnumed.116.178665. Epub 2016 Aug 4.